Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Novartis ADR
Today
Create an eToro account to buy NVS stock on a secure, user-friendly, multi-asset trading platform.
Buy Novartis ADR
Buy Novartis ADR
Novartis ADR NVS
Buy NVS
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Hold
Price Target
125
Based on analysts who covered NVS

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Novartis ADR News

Stocks-NVS-Novartis ADR

Novartis ADR NVS

$115.572.7(2.39%)(1D)
• NYSE • in USD

NVS Stock Price Chart

‎8.8‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Novartis ADR share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Novartis ADR share price today is $115.57, reflecting a ‎2.39‎% change over the last 24 hours and ‎6‎% over the past week. The current market capitalization of NVS is 228.26B with an average volume in the last three months of 1.8M. The stock has a P/E ratio of 19.54 and a dividend yield of 3.37%. With the stock’s beta sitting at 0.34
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$228.26B
Day’s Range
i
Shows the high and low prices of the day.
105.95 - 115.78
52W Range
i
Shows the high and low prices of the last year.
92.21 - 120.71
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.8M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
19.54
Revenue
i
The total income generated by this company’s goods and services last year.
$50.32B
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
3.28 (3.37%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$115.57
EPS
i
A company’s total earnings divided by the number of shares it has issued.
5.91
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.34
What Is Novartis ADR?
Operating internationally, Novartis is a pharmaceutical company that develops, manufactures, and markets ophthalmic products, biosimilars, branded and generic prescription drugs, and active pharmaceutical ingredients (APIs). Founded in 1996 as the result of a merger between Ciba-Geigy and Sandoz, the company has its headquarters in Basel, Switzerland.

Novartis mainly focuses on treatments for health problems related to cancer, cardiometabolism, immunology and dermatology, neuroscience, ophthalmology, and respiratory diseases. The company operates through two divisions: Innovative Medicines and Sandoz. Novartis' Innovative Medicines division is comprised of two business units: Novartis Pharmaceuticals and Novartis Oncology. The company's Innovative Medicines division develops and produces patent-protected prescription medicines for cancer, blood pressure, and other ailments. Through the Sandoz division, Novartis develops and produces generic pharmaceuticals and biosimilars.

Stock for Novartis is listed on the NYSE under the ticker NVS. The company also operates the Novartis Institutes for BioMedical Research (NIBR), which focus on discovering new drugs that can change the practice of medicine. Novartis operates six research campuses and has 5,600 employees dedicated to discovering new treatments. As of December 2021, Novartis products are used by nearly 800 million people globally, and the company employs approximately 108,000 people around the world.

Find NVS share price updates and additional relevant information by adding it to your eToro watchlist.
Buy NVS

How can I buy Novartis ADR stocks?

To purchase Novartis ADR:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Novartis ADR (NVS) page and place an order to buy Novartis ADR.
Buy NVS
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Novartis ADR
Invest in Novartis ADR
Today
Create an eToro account to buy NVS stock on a secure, user-friendly, multi-asset trading platform.
Buy NVS

FAQ

The current price of NVS is $115.57.
The average price target for Novartis ADR is $115.57. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Novartis ADR based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Novartis ADR is $228.26B
Daily Movers
Explore the biggest stocks movers on the market.
Buy NVS
Scroll to top